Improving Report of the ADAURA Trial by Distinguishing Treatment-Related Adverse Events From Treatment-Emergent Adverse Events and Assessing Independence of Censoring in Final Disease-Free Survival Analyses

被引:1
|
作者
Wu, Danna [1 ]
Li, Guo-Fu [2 ,3 ]
机构
[1] Hainan Med Univ, Hainan Gen Hosp, Dept Pharm, Hainan Affiliated Hosp, Haikou, Hainan, Peoples R China
[2] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Guo Yus Lab, Nanjing, Jiangsu, Peoples R China
[3] Subei Peoples Hosp, Yangzhou, Peoples R China
关键词
D O I
10.1200/JCO.23.00604
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:4317 / +
页数:3
相关论文
共 21 条
  • [1] Improving report of the ADAURA trial by distinguishing treatment-related adverse events from treatment-emergent adverse events and assessing independence of censoring in final disease-free survival analyses Reply
    Herbst, Roy S.
    Wu, Yi-Long
    Tsuboi, Masahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (26) : 4318 - U168
  • [2] Impact of obesity on treatment-related adverse events, disease recurrence, and survival in women with cervical carcinoma
    Gross, Jeffrey P.
    Strauss, Jonathan B.
    Lurain, John
    Berry, Emily
    Neubauer, Nikki
    Helenowski, Irene
    Donnelly, Eric D.
    JOURNAL OF RADIATION ONCOLOGY, 2016, 5 (02) : 197 - 203
  • [3] Algorithmic Identification of Treatment-Emergent Adverse Events From Clinical Notes Using Large Language Models: A Pilot Study in Inflammatory Bowel Disease
    Silverman, Anna L.
    Sushil, Madhumita
    Bhasuran, Balu
    Ludwig, Dana
    Buchanan, James
    Racz, Rebecca
    Parakala, Mahalakshmi
    El-Kamary, Samer
    Ahima, Ohenewaa
    Belov, Artur
    Choi, Lauren
    Billings, Monisha
    Li, Yan
    Habal, Nadia
    Liu, Qi
    Tiwari, Jawahar
    Butte, Atul
    Rudrapatna, Vivek
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S768 - S768
  • [4] Algorithmic Identification of Treatment-Emergent Adverse Events From Clinical Notes Using Large Language Models: A Pilot Study in Inflammatory Bowel Disease
    Silverman, Anna L.
    Sushil, Madhumita
    Bhasuran, Balu
    Ludwig, Dana
    Buchanan, James
    Racz, Rebecca
    Parakala, Mahalakshmi
    El-Kamary, Samer
    Ahima, Ohenewaa
    Belov, Artur
    Choi, Lauren
    Billings, Monisha
    Li, Yan
    Habal, Nadia
    Liu, Qi
    Tiwari, Jawahar
    Butte, Atul J.
    Rudrapatna, Vivek A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1391 - 1399
  • [5] The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials
    Doty, Erin G.
    Hauck, Paula M.
    Krege, John H.
    Komori, Mika
    Hake, Ann M.
    Dong, Yan
    Lipton, Richard B.
    CNS DRUGS, 2022, 36 (07) : 771 - 783
  • [6] The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials
    Erin G. Doty
    Paula M. Hauck
    John H. Krege
    Mika Komori
    Ann M. Hake
    Yan Dong
    Richard B. Lipton
    CNS Drugs, 2022, 36 : 771 - 783
  • [7] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to race: Post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    Savic, N.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [8] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: Post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Poewe, W.
    Ikedo, F.
    Magalhaes, D.
    Rocha, F.
    Soares-da-Silva, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [9] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: post-hoc analysis from double-blind combined BIPARK-I and II data
    Ikedo, F.
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Poewe, W.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S48 - S48
  • [10] Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline disease severity: post-hoc analysis from double-blind combined BIPARK-I and II data
    Costa, R.
    Lees, A.
    Ferreira, J.
    Rascol, O.
    Stocchi, F.
    Gama, H.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S37 - S37